Skip to main content
logo
Sino Biopharmaceutical Limited (HKG:1177)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
7.48
+0.23 (3.17%)
Aug 5, 2025, 4:08 PM HKT

Ligand Pharmaceuticals Revenue

In the year 2024, Sino Biopharmaceutical had annual revenue of 28.87B CNY with 10.18% growth. Sino Biopharmaceutical had revenue of 12.99B in the half year ending December 31, 2024.

Revenue
28.87B CNY
Revenue Growth
+14.93%
P/S Ratio
4.35
Revenue / Employee
1.18M CNY
Employees
24,379
Market Cap
133.78B USD

Revenue Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202428.87B2.67B10.18%
Dec 31, 202326.20B173.25M0.67%
Dec 31, 202226.03B-835.19M-3.11%
Dec 31, 202126.86B3.21B13.59%
Dec 31, 202023.65B-586.81M-2.42%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
BeOne Medicines32.49B
Hansoh Pharmaceutical Group Company13.05B
Innovent Biologics10.03B
JD Health International61.89B
Akeso2.26B
WuXi Biologics19.87B
CSPC Pharmaceutical Group28.99B
Sichuan Kelun-Biotech Biopharmaceutical2.06B
Revenue Rankings

Sino Biopharmaceutical News

More News